City Osteoporosis Center

Exclamation.svg

Dear

Exclamation.svg

patients

To carry out a consultation at the city osteoporosis center you need to have:1. Extract from the clinic at the place of residence regarding past illnesses2. Biochemical blood test (calcium, phosphorus, AST, ALT, urea, creatinine, alkaline phosphatase, total protein), blood test for vitamin D.3. Passport, mask, shoe covers4. Densitometry results.PAID SERVICES:  +375 (17) 322-65-59

image

Yatskovskaya Ekaterina Arkadyevna

The head of the department is a rheumatologist of the first qualification category, more than 15 years of experience.

The office is located on the 1st floor of the main therapeutic building.

+375 (17) 270-91-93

Yatskovskaya Ekaterina Arkadyevna

The head of the department is a rheumatologist of the first qualification category, more than 15 years of experience.

The office is located on the 1st floor of the main therapeutic building.

+375 (17) 270-91-93

Аbout the department

In the osteoporosis department (Minsk City Center for Osteoporosis and Diseases of the Musculoskeletal System), you can consult, be examined, and also undergo osteoporosis treatment from the best doctors in Minsk.

For citizens of Minsk (if necessary) and for nonresident citizens, consultations with rheumatologists and examinations are provided on a paid basis, pre-registration by phone:

+375 (17) 322-65-59

Registration for paid services is carried out according to the schedule:

July 29for September
September 2for October
October 1for November
November 1for December

The most common disease of the musculoskeletal system is osteoarthritis , which affects up to 20% of the population of our planet. With age, the incidence of osteoarthritis increases; in people over 50 years of age it is 27%, in people over 60 years of age it reaches 90%.

Treatment of osteoarthritis of various etiologies is still mainly symptomatic with the use of analgesics and anti-inflammatory drugs. In recent years, chondroprotectors have begun to be actively used for the treatment of osteoarthritis. This is a group of structure-modifying drugs, the action of which is based on a direct effect on the metabolism of cartilage tissue, stimulation of regeneration and reparative capabilities of chondrocytes. The use of chondroprotectors slows down degenerative changes in the joints and spine, has a delayed anti-inflammatory and analgesic effect, and allows for a long-term effect.

Osteoporosis is a chronic disease characterized by a gradual decrease in bone strength and an increased risk of fractures. Reducing bone mass is a gradual and painless process, so there are usually no specific, characteristic symptoms that would suggest that a patient is developing osteoporosis. This is why this disease is often called the “silent epidemic.” Osteoporosis affects every third woman and every eighth man over 50 years of age. In Europe, there is one osteoporotic fracture every 30 seconds.

Most often, the first manifestation of osteoporosis is a fracture. In some cases, but not always, visible signs of osteoporosis in a patient include a hunched back and decreased height due to fractures of fragile vertebrae.

Since the disease does not have characteristic clinical symptoms, doctors can prescribe an examination taking into account the patient’s age and the presence of risk factors for developing the disease.

Risk factors for osteoporosis can be divided into 2 groups: predisposing (independent of the person himself) and modifiable (depending on lifestyle and behavior and can be eliminated).

Although predisposing factors (including age, gender, and family history) determine whether a person is at increased risk for osteoporosis, modifiable factors play a key role in the development of the disease. Modifiable factors, such as proper nutrition and physical activity, help build healthy bone tissue in youth and maintain bone density in adulthood, preventing bone loss in older people. This means that it is within the power of every person to maintain their bone tissue and prevent its decline throughout life.

The gold standard for early diagnosis of osteoporosis is the measurement of bone mineral density - X-ray densitometry . This is a painless test that takes a few minutes. Densitometry results will help assess the risk of developing fractures and select the necessary treatment.

The initial appointment is by appointment. Appointment vouchers, in accordance with the established schedule, are distributed among city clinics, in proportion to the population living in the territory of a given clinic. For repeated admission of dispensary patients, a reserve of coupons is provided.

Based on the results of the consultation, dispensary and dynamic observation groups are formed with the development and monitoring of the implementation of individual rehabilitation programs and preventive measures in order to slow down the rate of progression of osteoporosis and its complications.

If there are indications, the patient, upon the referral of the Center’s doctors, undergoes an additional examination on an outpatient basis at the 1st City Clinical Hospital: biochemical blood test, blood test for markers of bone metabolism, X-ray densitometry.

Doctors of the department

  1. Evdokimova A.M. – radiologist of the densitometry room of the first qualification category
  2. Fomin O.Yu. -  rheumatologist of the highest qualification category (work experience 25 years)
  3. Mikheeva E.A. – rheumatologist of the second qualification category
  4. Zherko D.S. – radiologist of the first qualification category (work experience 21 years)
  5. Samokhovets A.Yu. – rheumatologist of the first qualification technology (work experience 11 years)
  6. Skrypnik E.Yu. – rheumatologist (work experience more than 10 years)

Work in the osteoporosis department (Minsk City Center for Osteoporosis and Diseases of the Musculoskeletal System) is currently organized from 8.00. until 20.00 daily. 

There is also a paid reception on Saturday from 8.30 to 15.00.

Pre-registration by phone +375 (17) 322-65-59.